Research

The Institute has a number of research teams examining different aspects of nerve and muscle disease. The aim of this research is to advance our understanding of the disorders from both a research and clinical perspective.

Here's a list of the main research areas:

Brain Autoimmunity - Aims to understand the role played by autoantibodies in neurological diseases including Autoimmune Encephalitis, emyelinating syndromes, movement disorders and early-onset psychosis.

Clinical Neuroimmunology - Aims to define the clinical features and best treatment of immune mediated brain conditions, including autoimmune encephalitis, autoimmune movement disorders and the immune contribution of common disorders such as epilepsy and neuropsychiatric conditions such as tics and obsess-compulsive disorder.

Clinical Trial and Clinical Research - Provides an interface between clinical care and scientific research for a range of conditions that affect the brain, nerve and muscle.

Disease Mechanisms and Therapies - Using cell and animal models to unlock the mechanisms causing nerve and muscle disorders to inform evidence-based therapies.

Epilepsy and Movement disorders - Explores clinical care and research in complex epilepsy, epilepsy genetics and epilepsy surgery, and in movement disorders undertakes research in Tourette Syndrome and genetic dystonia. This includes collaboration in gene discovery projects and deep brain stimulation.

Neurofibromatosis Type 1 (NF1) - Focuses on the cognitive, psychosocial and learning aspects of children and adolescents with NF1.

Neuromuscular Gene Discovery - Translating latest innovations in genomics to provide families with a precise genetic diagnosis, and identify novel genes causing disease.

Neuropathy - Aims to improve the lives of children with Charcot-Marie-Tooth disease through effective clinical trials and clinical trials.

This research translates into specific projects. Take a look at our current ones:

  • identifying new forms of muscular dystrophies.
  • unlocking the mystery of inherited congenital myopathies.
  • develop learning strategies to help children with NF1 reach their full potential.
  • determining the cause of a fatal neuropathy of infants.
  • delivering new therapies to children with neuromuscular disorders.

The Institute works in collaboration with a network of Australian and international collaborators. INMR offers various study and work opportunities: take a look.

 

Did you know?

It would take a person typing 60 words per minute, eight hours a day around 50 years to type the human genome!

Donate
Photo of a typewriter